Presentation ESC 2025 Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial Presenter: David Newby September 03, 2025
Presentation ESC 2025 Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial Presenter: Anders Jeppsson September 01, 2025
Presentation ESC 2025 Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial Presenter: Duk-Woo Park August 31, 2025
Presentation ESC 2025 Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial Presenter: Robin Hofmann August 31, 2025
Presentation ESC 2025 PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial Presenter: Pedro A. Lemos August 30, 2025
Presentation ESC 2024 INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population Presenter: David Erlinge September 02, 2024
Presentation ESC 2024 RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence Presenter: Derek Chew September 02, 2024
Presentation ESC 2023 Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease Presenter: Simone Biscaglia August 28, 2023
Presentation ESC 2023 Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock: ECLS-SHOCK Presenter: Holger Thiele August 28, 2023
Presentation ESC 2023 ARREST Trial: Expedited Transfer to a Cardiac Arrest Centre for non-ST Elevation OHCA Presenter: Tiffany Patterson August 28, 2023
Presentation ESC 2022 FFR vs. Angiography-guided PCI in AMI with multivessel disease Presenter: Joo-Yong Hahn August 29, 2022
Presentation ESC 2022 Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction Presenter: John H. Alexander August 28, 2022
Presentation ESC 2022 Coronary Atherosclerotic Plaque Activity and Future Coronary Events Presenter: David Newby August 28, 2022
Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019
Presentation ESC 2019 A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes Presenter: David B. Brieger September 01, 2019
Presentation ESC 2018 2018 ESC/EACTS Guidelines on Myocardial Revascularization Presenter: Franz-Josef Neumann August 30, 2018
Presentation ESC 2018 Canadian Spontaneous Coronary Artery Dissection Cohort Study Presenter: Jacqueline Saw August 30, 2018
Presentation ESC 2018 ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Presenter: Robert Byrne August 29, 2018
Presentation ESC 2018 FUnctional Testing Underlying REvascularization The FUTURE trial Presenter: Gilles Rioufol August 26, 2018